Is ICL a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Potash pricing against a low cost Dead Sea position, with revenue (ttm) at ~$7.7B, with Q2 2026 sales of ~$2.14B up ~17% year over year. The bear case rests on the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Analysts covering it are spread from $5.50 to $6.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $5.50, -0.9% from the $5.55 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Potash pricing against a low cost Dead Sea position. ICL realised ~$376 per tonne CIF on potash in the second quarter of 2026, about ~13% above the same quarter of 2025 and ~4% above the first quarter, and Potash segment EBITDA rose to ~$154 million from ~$115 million. The most optimistic analyst target on ICL is $6.00, +8.1% from the $5.55 price. That figure is only reachable if this thesis works close to its best case.

The Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Israeli country risk is concrete rather than theoretical here: the security situation has produced recurring charges, shekel appreciation lifts a cost base that sells in dollars, and regional shipping disruption affects both input costs and exports. Earnings remain levered to potash and phosphate pricing, so a soft grain year would give back a good part of the 2026 recovery. Net financial liabilities rose ~$375 million in the first half to about ~$2,635 million following an ~$800 million ten year note issue at ~6.036%, comfortable at roughly ~1.6 times adjusted EBITDA but less forgiving if prices turn. Several Israeli environmental and planning matters remain open, including petitions over the Pond 4 reuse plan and an appeal against the dismissal of a Haifa Bay air pollution class action, and none of these are securities fraud claims. The most pessimistic published target is $5.50, -0.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

ICL Group is an Israeli specialty minerals company that mines potash and bromine from the Dead Sea and sells phosphate and plant nutrition products worldwide.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Potash pricing against a low cost Dead Sea position) stalling in the reported numbers rather than in the narrative, the risk above (the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It is a specialty minerals and chemicals company built on two mineral endowments: the highly concentrated brine of the Dead Sea, which yields potash, bromine and magnesium, and phosphate rock from the Negev desert and China. Those raw materials feed four segments covering flame retardants, potash fertiliser, phosphate specialties for food and industry, and specialty plant nutrition.

It is an ordinary share. ICL registered its ordinary shares of NIS 1.00 par value under Section 12(b) with the New York Stock Exchange under the symbol ICL, and the same shares are dual listed on the Tel Aviv Stock Exchange. There is no separate ADR ratio to account for, and roughly ~1.29 billion shares were outstanding at the end of 2025.

Yes, quarterly. The board declared ~$0.06 per share on August 4, 2026, payable September 16, 2026, after ~$0.05 in each of the two prior quarters. Policy is a payout of up to ~50% of adjusted annual net income, which means the dividend moves with the fertiliser cycle rather than following a fixed growth path.